Google
Trusted Resources: News & Events
Latest announcements and gatherings
University Hospitals program uses music to teach about sickle cell (photos, video)
The study looked at Seidman’s BEATS (Build, Educate, Advance, Transition in Sickle cell disease) music therapy program, developed by Rodgers-Melnick. BEATS focuses on young adults ages 18-35 who have transitioned from pediatric care at Rainbow Babies and Children’s Hospital to an adult care program at Seidman.
To help young adults with their transition to adult care, doctors at Seidman developed the “Bridge Clinic,” a care team that includes a hematologist, nurses and social worker, as well as one-hour BEATS music therapy sessions that Rodgers-Melnick leads.
Each week, BEATS participants create a different song about how the disease affects the body, what to do if they develop a fever or pneumonia, pain management techniques and other topics. The program currently has 50 participants.
+myBinderRelated Content
-
Sickle Cell DiseaseSickle cell disease (SCD) is a group of ...
-
Partnership to Ensure Supply of LentiGlobin, Potential Gene TherapyBluebird Bio extended a partnership with...
-
Sickle Cell Foundation Nigeria, Rhieos Develop 1st Multi-SCD Registry in NigeriaIn a bid to improve quality of care for ...
-
Gene Therapy: Your Questions Answeredhttps://www.youtube.com/watch?v=5ChXI6cS...
-
Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRI...Background: Hematopoietic cell transplan...
-
ADDMEDICA receives FDA-approval for orphan drug Siklos®, first and sole hydroxyurea-based treatment for paediatric ...ADDMEDICA has announced that the...
-
Sickle Cell Disease Association of America, Inc. and Hemanext® Inc. Form New Strategic PartnershipSickle Cell Disease Association of Ameri...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.